Mycobactericidal Activity of Sutezolid (PNU-100480) in Sputum (EBA) and Blood (WBA) of Patients with Pulmonary Tuberculosis-Reference-Cited by-同舟云学术

Mycobactericidal Activity of Sutezolid (PNU-100480) in Sputum (EBA) and Blood (WBA) of Patients with Pulmonary Tuberculosis

Published:2014-04-14 Issue:4 Volume:9 Page:e94462
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Wallis Robert S.,Dawson Rodney,Friedrich Sven O.,Venter Amour,Paige Darcy,Zhu Tong,Silvia Annette,Gobey Jason,Ellery Craig,Zhang Yao,Eisenach Kathleen,Miller Paul,Diacon Andreas H.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference22 articles.

1. World Health Organization (2010) Multidrug and extensively drug-resistant TB (M/XDR-TB): 2010 Global report on surveillance and response. WHO/HTM/TB/2010.3.

2. Inhibition of mammalian mitochondrial protein synthesis by oxazolidinones;EE McKee;Antimicrob Agents Chemother,2006

3. Linezolid for the treatment of chronic extensively drug-resistant tuberculosis;M Lee;N Engl J Med,2012

4. Addition of PNU-100480 to first-line drugs shortens the time needed to cure murine tuberculosis;KN Williams;Am J Respir Crit Care Med,2009

5. Biomarker assisted dose selection for safety and efficacy in early development of PNU-100480 for tuberculosis;RS Wallis;Antimicrob Agents Chemother,2011

Cited by 125 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development and application of the direct mycobacterial growth inhibition assay: a systematic review;Frontiers in Immunology;2024-02-06

2. Power to identify exposure‐response relationships in phase IIa pulmonary tuberculosis trials with multi‐dimensional bacterial load modeling;CPT: Pharmacometrics & Systems Pharmacology;2023-12-15

3. Non-tuberculous mycobacterial disease: progress and advances in the development of novel candidate and repurposed drugs;Frontiers in Cellular and Infection Microbiology;2023-10-02

4. Antibiotics in the clinical pipeline as of December 2022;The Journal of Antibiotics;2023-06-08

5. Molecular diagnostics and potential therapeutic options for mycobacterium tuberculosis: Where we stand;Medicine in Omics;2023-06